Literature DB >> 21531565

The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation.

Michelle C Mendoza1, E Emrah Er, John Blenis.   

Abstract

The Ras-extracellular signal-regulated kinase (Ras-ERK) and phosphatidylinositol 3-kinase-mammalian target of rapamycin (PI3K-mTOR) signaling pathways are the chief mechanisms for controlling cell survival, differentiation, proliferation, metabolism, and motility in response to extracellular cues. Components of these pathways were among the first to be discovered when scientists began cloning proto-oncogenes and purifying cellular kinase activities in the 1980s. Ras-ERK and PI3K-mTOR were originally modeled as linear signaling conduits activated by different stimuli, yet even early experiments hinted that they might intersect to regulate each other and co-regulate downstream functions. The extent of this cross-talk and its significance in cancer therapeutics are now becoming clear.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21531565      PMCID: PMC3112285          DOI: 10.1016/j.tibs.2011.03.006

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  99 in total

1.  Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

Authors:  R Sears; F Nuckolls; E Haura; Y Taya; K Tamai; J R Nevins
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

2.  ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1).

Authors:  Audrey Carriere; Yves Romeo; Hugo A Acosta-Jaquez; Julie Moreau; Eric Bonneil; Pierre Thibault; Diane C Fingar; Philippe P Roux
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

3.  Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function.

Authors:  Xiao-Jun Qi; Gary M Wildey; Philip H Howe
Journal:  J Biol Chem       Date:  2005-11-10       Impact factor: 5.157

4.  Regulation of Raf-1 activation and signalling by dephosphorylation.

Authors:  Amardeep S Dhillon; Sharon Meikle; Zihni Yazici; Manfred Eulitz; Walter Kolch
Journal:  EMBO J       Date:  2002-01-15       Impact factor: 11.598

Review 5.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

6.  The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells.

Authors:  Qing-Bai She; David B Solit; Qing Ye; Kathryn E O'Reilly; Jose Lobo; Neal Rosen
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

7.  pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167.

Authors:  P B Joel; J Smith; T W Sturgill; T L Fisher; J Blenis; D A Lannigan
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

8.  Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.

Authors:  Mitchell Cheung; Arati Sharma; SubbaRao V Madhunapantula; Gavin P Robertson
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

9.  AGC kinases regulate phosphorylation and activation of eukaryotic translation initiation factor 4B.

Authors:  A G M van Gorp; K E van der Vos; A B Brenkman; A Bremer; N van den Broek; F Zwartkruis; J W Hershey; B M T Burgering; C F Calkhoven; P J Coffer
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

10.  Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF, PMA and AICAR.

Authors:  Kathryn M Geraghty; Shuai Chen; Jean E Harthill; Adel F Ibrahim; Rachel Toth; Nick A Morrice; Franck Vandermoere; Greg B Moorhead; D Grahame Hardie; Carol MacKintosh
Journal:  Biochem J       Date:  2007-10-15       Impact factor: 3.857

View more
  639 in total

1.  Control of FLIP(L) expression and TRAIL resistance by the extracellular signal-regulated kinase1/2 pathway in breast epithelial cells.

Authors:  R Yerbes; A López-Rivas; M J Reginato; C Palacios
Journal:  Cell Death Differ       Date:  2012-06-22       Impact factor: 15.828

Review 2.  The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.

Authors:  Jesse Costales; Alexander Kolevzon
Journal:  Neurosci Biobehav Rev       Date:  2016-01-15       Impact factor: 8.989

3.  EZH2 Methyltransferase Activity Controls Pten Expression and mTOR Signaling during Fear Memory Reconsolidation.

Authors:  Timothy J Jarome; Gabriella A Perez; Rebecca M Hauser; Katrina M Hatch; Farah D Lubin
Journal:  J Neurosci       Date:  2018-07-20       Impact factor: 6.167

4.  A genome-wide analysis of colorectal cancer in a child with Noonan syndrome.

Authors:  Rahul M Prasad; Rajen J Mody; George Myers; Melisa Mullins; Zaher Naji; James D Geiger
Journal:  Pediatr Blood Cancer       Date:  2018-07-24       Impact factor: 3.167

5.  The myonuclear DNA methylome in response to an acute hypertrophic stimulus.

Authors:  Ferdinand Von Walden; Matthew Rea; C Brooks Mobley; Yvonne Fondufe-Mittendorf; John J McCarthy; Charlotte A Peterson; Kevin A Murach
Journal:  Epigenetics       Date:  2020-04-28       Impact factor: 4.528

6.  Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis.

Authors:  Xiaojie Xu; Zhongyi Fan; Lei Kang; Juqiang Han; Chengying Jiang; Xiaofei Zheng; Ziman Zhu; Huabo Jiao; Jing Lin; Kai Jiang; Lihua Ding; Hao Zhang; Long Cheng; Hanjiang Fu; Yi Song; Ying Jiang; Jiahong Liu; Rongfu Wang; Nan Du; Qinong Ye
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

7.  Rapamycin Treatment Attenuates Angiotensin II -induced Abdominal Aortic Aneurysm Formation via VSMC Phenotypic Modulation and Down-regulation of ERK1/2 Activity.

Authors:  Fei-Fei Li; Xiao-Ke Shang; Xin-Ling Du; Shu Chen
Journal:  Curr Med Sci       Date:  2018-03-15

Review 8.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

Review 9.  Regulation of interferon-dependent mRNA translation of target genes.

Authors:  Barbara Kroczynska; Swarna Mehrotra; Ahmet Dirim Arslan; Surinder Kaur; Leonidas C Platanias
Journal:  J Interferon Cytokine Res       Date:  2014-02-21       Impact factor: 2.607

Review 10.  Two is better than one; toward a rational design of combinatorial therapy.

Authors:  Sheng-Hong Chen; Galit Lahav
Journal:  Curr Opin Struct Biol       Date:  2016-08-10       Impact factor: 6.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.